Takeda's subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative...
Takedas subcutaneous formulation of its gutselective biologic vedolizumab has secured recommendation from the European Medicines Agencys EMA Committee for Medicinal Products for Human Use CHMP it has...
View ArticleA Selective JAK inhibitor Shows Promise for Crohn Disease
A phase II trial demonstrates efficacy compared with placebo.
View ArticleCrohn's Disease Ulcerative Colitis and Lipid Profiles
The populationbased study evaluated the association of developing IBD with serum lipid profiles. Did Crohn's disease and ulcerative colitis patients differ in their profile characteristics Alimentary...
View ArticleHistone Deacetylase 6 Pipeline Review H2 2019 Published by Global Markets...
Histone Deacetylase 6 Pipeline Review H2 2019SummaryHistone Deacetylase 6 Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98 pipeline Target constitutes close to 49 molecules. Out of...
View ArticleGelesis Named One of the Worlds Most Innovative Companies for 2020 by Fast...
Gelesis a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal GI tract has been named to Fast Companys...
View ArticleInnovate Biopharmaceuticals Affirms Timeline for Closing of Merger with RDD...
Israeli Regulatory Approvals Appear on Track for Late March 2020 to Allow Closing of the MergerRALEIGH NC ACCESSWIRE March 11 2020 Innovate Biopharmaceuticals Inc. NASDAQINNT a clinicalstage...
View ArticleCan poor air quality make you gain weight
University of Colorado at Boulder A new study links air pollution to changes in the human gut microbiome which could fuel diabetes obesity and inflammatory bowel diseases like colitis and Crohn's disease.
View ArticleProfiles in Creating Possible Julie Di Paolo is on a Mission to Understand...
SOURCE Gilead SciencesDESCRIPTIONWhen Julie Di Paolos father was diagnosed with Crohns disease an inflammatory condition with limited treatment options it sparked curiosity and drive that have carried...
View ArticleFormaldehyde Dehydrogenase Pipeline Review H2 2019 Published by Global...
Formaldehyde Dehydrogenase Pipeline Review H2 2019SummaryAccording to the recently published report 'Formaldehyde Dehydrogenase Pipeline Review H2 2019'; Formaldehyde Dehydrogenase S Nitrosoglutathione...
View ArticleAbivax 2019 Financial Results and Operations Update
ABX464 Phase 2a ulcerative colitis maintenance study showed excellent longterm efficacy and continued safetyABX464 Phase 2b ulcerative colitis study progressing well in 15 European countries and Canada...
View ArticleAbivax 2019 Financial Results and Operations Update news with additional...
DGAPNews ABIVAX Key words Annual Results16.03.2020 1932 The issuer is solely responsible for the content of this announcement.Abivax 2019 Financial Results and Operations Update ABX464 Phase 2a...
View ArticleA protein that controls inflammation
VIB the Flanders Institute for Biotechnology A study by the research team of Prof. Geert van Loo VIBUGent Center for Inflammation Research has unraveled a critical molecular mechanism behind autoimmune...
View ArticleStudy unravels molecular mechanism behind autoimmune and inflammatory diseases
A study by the research team of Prof. Geert van Loo VIBUGent Center for Inflammation Research has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid...
View ArticleUbiquitination of a Single Protein Could Be Key for Autoimmune Disorders
A team of investigators at the Flanders Institute For Biotechnology VIB has unraveled a key molecular mechanism behind the inflammatory response which could be extraordinarily helpful in treating...
View Article. VIBLifeSciences researchers unravel a key molecular mechanism behind the...
. VIBLifeSciences researchers unravel a key molecular mechanism behind the inflammatory response which could be extraordinarily helpful in treating diseases such as rheumatoid arthritis...
View ArticleCrohns Disease Ups Colorectal Cancer Risk
MedPage Today Study Authors Ola Ol&233;n Rune Erichsen et al.; Jason K. HouTarget Audience and Goal Statement Gastroenterologists oncologistsThe goal of this study was to determine the rates of...
View ArticleÂPfizer Announces Positive TopLine Results from Third Phase 3 Trial of...
ÂJADE COMPARE trial met all coprimary endpointsStudy included dupilumab in active control armSafety profile for abrocitinib consistent with previous studiesPfizer Inc. NYSEPFE announced today that JADE...
View ArticleGlobal Ostomy Products Market 20202024 Evolving Opportunities with 3M Co. and...
The global ostomy products market is poised to grow by USD 1.05 billion during 20202024 progressing at a CAGR of over 5 during the forecast period. Request free sample pagesThis press release features...
View Article